Patents
Patents for C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
03/2015
03/04/2015EP2842952A1 Method for producing zaltoprofen and derivative thereof
10/2014
10/30/2014US20140323412 Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease
10/16/2014US20140309437 Process for the preparation of pharmaceutical intermediates
08/2014
08/28/2014US20140243281 Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases
08/19/2014US8809553 Process for the preparation of pteridine derivatives
06/2014
06/04/2014CN1585772B Chemokine receptor antagonists and methods of use thereof
10/2013
10/31/2013WO2013161842A1 Method for producing zaltoprofen and derivative thereof
10/31/2013WO2013131521A8 Open-cage fullerenes and a method for preparing the same
09/2013
09/26/2013WO2013141264A1 Novel cysteine compound and salt thereof
09/12/2013WO2013131521A1 Open-cage fullerenes and a method for preparing the same
06/2013
06/25/2013CA2747424C 1-heterodiene derivative and harmful organism control agent
06/11/2013US8461312 Method for the production of 1,4-benzothiepin-1,1-dioxide derivatives
05/2013
05/02/2013US20130108573 Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease
01/2013
01/23/2013CN101565393B 3-(substituted bisulfonyl fluromethane)-1-propylene compound, synthetic method and applications thereof
05/2012
05/29/2012US8188141 Isomigrastatin analogs in the treatment of cancer
04/2012
04/25/2012EP1719768B1 Novel benzothiazepine and benzothiepine compounds
02/2012
02/09/2012US20120035170 Novel unsaturated tetracyclic tetrahydrofuran derivatives
01/2012
01/19/2012US20120015925 Novel benzothiazepine and benzothiepine compounds
01/12/2012US20120009519 Compound, resin and photoresist composition
12/2011
12/28/2011CN102293773A 含有苯并硫氮杂卓和苯并虑平化合物的药物 Benzothiazepine and benzo drugs containing compounds doxepin
11/2011
11/29/2011US8067584 Benzothiazepine derivatives
11/16/2011CN102245571A 1-heterodiene derivative and harmful organism control agent
11/10/2011US20110275695 Crystalline forms of zotepine hydrochloride
10/2011
10/26/2011EP2380876A1 1-heterodiene derivative and harmful organism control agent
10/06/2011US20110245486 Method for the production of 1,4-benzothiepin-1,1-dioxide derivatives
09/2011
09/15/2011US20110224276 optical isomer of phenylpropionic acid and its medicinal use
09/14/2011CN102180849A Diaryl diene cyclic ketone derivatives, and preparation method and application thereof
07/2011
07/20/2011CN1930137B Novel benzothiazepine and benzothiepine compounds
07/05/2011US7973030 Benzothiazepine and benzothiepine compounds
06/2011
06/28/2011CA2467672C Chemokine receptor antagonists and methods of use therefor
04/2011
04/27/2011EP1891035B1 Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs
04/21/2011US20110092564 Cyclic amino acids for the treatment of pain
04/12/2011US7923468 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with cyclohexyl groups, method for producing the same, drugs containing said compounds and use thereof
03/2011
03/29/2011CA2489276C Tricyclic steroid hormone nuclear receptor modulators
02/2011
02/23/2011EP2286811A1 Chemokine receptor antagonists and methods of use thereof
02/16/2011EP2282991A2 Method for the production of 1,4-benzothiepin-1,1-dioxide derivatives
02/15/2011US7888400 Dental compositions containing hybrid monomers
02/03/2011WO2011012987A1 Pharmaceutical composition of isoniazid
12/2010
12/28/2010US7858613 Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs
12/02/2010WO2010137620A1 Phenoxyethylamine derivative
10/2010
10/28/2010US20100273791 Tricyclic pyrazole derivatives as cannabinoid receptor modulators
08/2010
08/25/2010CN101812049A Method for preparing zaltoprofen
07/2010
07/29/2010US20100189762 Triarylmethane analogs and their use in treating cancers
06/2010
06/24/2010WO2010070910A1 1-heterodiene derivative and harmful organism control agent
06/24/2010US20100160410 Use of pentadienoic acid derivatives for the treatment of hyperuricemia
06/24/2010CA2747424A1 1-heterodiene derivative and harmful organism control agent
06/15/2010US7737269 Process for preparing an alpha-lipoic acid/cyclodextrin complex and product prepared
06/03/2010US20100137599 Process for preparing 1,4-butandiol monitrate
05/2010
05/06/2010WO2009132832A3 Method for the production of 1,4-benzothiepin-1,1-dioxide derivatives
04/2010
04/15/2010WO2009152347A3 Crystalline forms of zotepine hydrochloride
03/2010
03/23/2010CA2356680C Benzopyrans and benzoxepines, pharmaceutical compositions comprising them and preparation process
02/2010
02/09/2010CA2557576C Novel benzothiazepine and benzothiepine compounds
01/2010
01/26/2010US7652003 Macrocyclic β-secretase inhibitors
12/2009
12/17/2009WO2009152347A2 Crystalline forms of zotepine hydrochloride
11/2009
11/05/2009DE102008022017A1 Preparing 1,4-benzothiepin-1,1-dioxide derivative, comprises e.g. reacting mercaptomethyl-hexanol compound with difluorobenzoyl-azinic acid compound and converting into e.g. benzo(b)thiepin-4-ol compound followed by isolating and purifying
10/2009
10/28/2009CN101565393A 3-(substituted bisulfonyl fluromethane)-1-propylene compound, synthetic method and applications thereof
10/22/2009US20090264661 Methods for producing cyclic phenol sulfides
10/13/2009CA2334775C Benzo(b)thiepine-1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
09/2009
09/24/2009US20090239169 Oxidized mixed cyclic phenol sulfide having 6 or 8 benzene rings and an equal number of sufones as the charge control agent in toners for electrography, electrostatic processes; particularly useful for color toners; speeds up charging risetime; high charge amount; stability in hot, humid envirnment
08/2009
08/27/2009US20090215858 such as Pentylcarbamic acid 5-oxo-2,3,4,5-tetrahydrobenzo[b]thiepin-4-ylmethyl ester, having a high affinity for vanilloid receptors and/or cannabinoid receptors, used as analgesics or for the treatment of neuropathic pain
08/05/2009EP2084143A1 Novel 1,4-benzothiepin-1,1 -dioxide derivatives which are substituted with cyclohexyl groups, method for producing the same, drugs containing said compounds and use thereof
06/2009
06/11/2009US20090149445 Tricyclic steroid hormone nuclear receptor modulators
05/2009
05/27/2009EP2061755A1 Tricyclic compounds useful in treating iron disorders
05/27/2009EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators
05/26/2009CA2334773C Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use
04/2009
04/23/2009US20090105327 Dibenzocycloheptane compounds and pharmaceuticals containing these compounds
04/14/2009CA2256007C Substituted heterocyclic benzocycloalkenes and their use as analgesic
04/08/2009EP1448566B3 Chemokine receptor antagonists and methods of use thereof
02/2009
02/18/2009CN100462362C Preparing process of 2-(10-oxy-10,11-dihydrodibenz[b,f]-thiotropilium-2-yl) propionic acid
02/05/2009US20090036420 Benzamide derivatives and their use for treating cns disorders
11/2008
11/06/2008WO2008133288A1 Tricyclic aryl compounds
10/2008
10/22/2008EP1425018B1 Combined preparations, containing 1,4-benzothiepine-1,1-dioxide derivatives and other active substances, and the use thereof
09/2008
09/18/2008DE102006053636B4 Neue mit Cyclohexylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate und deren Verwendung New with cyclohexyl substituted 1,4-benzothiepine-1,1-dioxide derivatives and their use
09/12/2008WO2008109840A1 Tricyclic compounds useful in treating iron disorders
09/12/2008CA2678895A1 Tricyclic compounds useful in treating iron disorders
09/03/2008CN101255153A 10,11-dihydro-alpha-methyl-10-oxo-dibenzo[b,f] tiazem-2-acetic optical isomers as well as preparation method and medical uses thereof
09/03/2008CN100415714C Preparing process of 5-propionyl-2-thiophenyl phenylacetate
09/02/2008US7420051 Antitumor agents; microbiocides; antibiotics; forming a 1,4 bridge using a 1-labile, 10-hydroxy, 18-protected hydroxyl, di-6,8-en-5-one fused ring compound. After formation of the 1,4 brige, C-18 protection is removed before spiroamine introduction
09/02/2008CA2248338C 2-amino-4-bicycloamino-1,3,5-triazines as herbicides and plant growth regulators
08/2008
08/26/2008US7417040 hormone sensitive diseases such as prostate hypertrophia, benign prostatic hyperplasia, adenomas and neoplasies of the prostate, prostate cancer, hirsutism, and polycystic ovary syndrome; dibenz[b,f]azocine, dibenzo[b,f][1,4]thiazocine, dibenz[b,f][1,5]oxazocine derivatives; anticancer, antitumor agents
08/14/2008WO2008096755A1 Vanilloid receptor (vr1) inhibitor and use thereof
08/12/2008US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease
08/12/2008US7410997 relaxing action of tracheal smooth muscles, inhibition of airway hypersensitivity and inhibition of infiltration of inflammatory cells into the airway; useful as antiasthmatic drugs
07/2008
07/02/2008EP1937677A1 Cb-1 modulating compounds and their use
06/2008
06/05/2008WO2008065796A1 α-GLUCOSIDASE INHIBITOR
05/2008
05/22/2008WO2008061029A1 Aryl sulfonamide derivatives and methods of their use
05/22/2008WO2008058629A1 Novel 1,4-benzothiepin-1,1 -dioxide derivatives which are substituted with cyclohexyl groups, method for producing the same, drugs containing said compounds and use thereof
05/15/2008DE102006053636A1 Neue mit Cyclohexylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung New-substituted 1,4-cyclohexyl-1,1-dioxide derivatives benzothiepine, processes for their preparation, pharmaceutical compositions containing them and their use
05/13/2008US7371853 Ring structuresC6.C6.C14N2O, C6.C6.C15N2O, C6.C6.C16N2O and C6.C6.C17N2O
04/2008
04/16/2008CN101161641A Tricyclic steroid hormone nuclear receptor modulators
03/2008
03/26/2008CN100376564C Substituted heterocyclic benzoeycloalkenes and the use thereof as substances having analgesic effect
02/2008
02/27/2008EP1891035A1 Substituted benzo-condensed cycloheptanone derivatives and their use for producing drugs
02/19/2008US7332516 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease
01/2008
01/09/2008CN100360519C Benzothiepine ileal bile acid transport inhibitors
12/2007
12/25/2007US7312203 1H-8-oxa-1-aza-dibenzo[e,h]azulene; dual inhibitors of tumour necrosis factor(alpha) and interleukin 1; antiinflammatory, analgesics
11/2007
11/27/2007US7301705 Alicyclic compound for optical material
10/2007
10/02/2007US7276532 Incontinence
08/2007
08/28/2007US7262309 Cyclization at the 5,6-position of the benzo[e]naphtho[3,2-h]azulene, oxepane or thiepane with a mercaptoacetic acid ester followed by etherification, amination or sulfiding at the 2-position; antiarthritic and antiinflammatory agents, analgesics; biosynthesis inhibitors of interleukin-1
08/16/2007US20070191469 Novel tetracyclic tetrahydrofuran derivatives
08/16/2007US20070190041 Novel benzothiazepine and bensothiepine compounds
1 2 3 4 5 6 7 8 9